9.26USD
474.62 MUSD
4.13 BUSD
50.25 M
About Charles River Laboratories International, Inc.
Sector
CEO
James C. Foster
Website
Headquarters
Wilmington
Employees (FY)
21.8 K
Founded
1947
ISIN
US1598641074
FIGI
BBG000BG5BL8
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CRL is 227.55 USD — it has decreased by 1.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Charles River Laboratories International, Inc. stocks are traded under the ticker CRL.
Charles River Laboratories International, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CRL stock is 4.58% volatile and has beta coefficient of 1.57. Check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
One year price forecast for Charles River Laboratories International, Inc. has a max estimate of 300.00 USD and a min estimate of 235.00 USD.
CRL earnings for the last quarter are 2.72 USD whereas the estimation was 2.36 USD which accounts for 15.40% surprise. Estimated earnings for the next quarter are 2.40 USD. See more details about Charles River Laboratories International, Inc. earnings.
Charles River Laboratories International, Inc. revenue for the last quarter amounts to 1.03 B USD despite the estimated figure of 1.00 B USD. In the next quarter revenue is expected to reach 991.25 M USD.
Yes, you can track Charles River Laboratories International, Inc. financials in yearly and quarterly reports right on TradingView.
CRL stock has fallen by 8.72% compared to the previous week, the month change is a 12.94% fall, over the last year Charles River Laboratories International, Inc. has showed a 10.98% increase.
CRL net income for the last quarter is 187.08 M USD, while the quarter before that showed 87.39 M USD of net income which accounts for 114.08% change. Track more Charles River Laboratories International, Inc. financial stats to get the full picture.
Today Charles River Laboratories International, Inc. has the market capitalization of 11.82 B, it has decreased by 2.64% over the last week.
No, CRL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Charles River Laboratories International, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 21.80 K employees. See our rating of the largest employees — is Charles River Laboratories International, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Charles River Laboratories International, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Charles River Laboratories International, Inc. stock shows the neutral signal. See more of Charles River Laboratories International, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Charles River Laboratories International, Inc. future price: according to them, CRL price has a max estimate of 300.00 USD and a min estimate of 235.00 USD. Read a more detailed Charles River Laboratories International, Inc. forecast: see what analysts think of Charles River Laboratories International, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Charles River Laboratories International, Inc. EBITDA is 967.26 M USD, and current EBITDA margin is 23.62%. See more stats in Charles River Laboratories International, Inc. financial statements.